Korro Bio, Inc.
KRRO
$14.48
$0.372.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.29% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.29% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 12.29% | -- | |||
| SG&A Expenses | -4.28% | 9.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.92% | 8.67% | |||
| Operating Income | -8.59% | 1.08% | |||
| Income Before Tax | -10.86% | -0.42% | |||
| Income Tax Expenses | -- | 1,244.44% | |||
| Earnings from Continuing Operations | -10.32% | -0.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.32% | -0.95% | |||
| EBIT | -8.59% | 1.08% | |||
| EBITDA | -9.22% | 2.85% | |||
| EPS Basic | -10.12% | -0.27% | |||
| Normalized Basic EPS | -10.66% | 0.26% | |||
| EPS Diluted | -10.12% | -0.27% | |||
| Normalized Diluted EPS | -10.66% | 0.26% | |||
| Average Basic Shares Outstanding | 0.18% | 0.69% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||